- A year after Vertex’s big launch, pain drug research faces a pivotal moment<p>Journavx revived an area of development long considered a graveyard. Can any other pain drugs keep investor excitement going?</p>BioPharma Dive · 2mo ago↗ source
- <![CDATA[Real-World Data Highlight Survival Benefit of Rituximab Maintenance After Frontline BR in MCL]]><![CDATA[Rituximab following first-line bendamustine demonstrated significant OS and EFS real-world benefits in mantle cell lymphoma.]]>onclive · 2mo ago↗ source
- <![CDATA[Dr Silbermann on Clinical Trial Design Considerations in Multiple Myeloma]]><![CDATA[Rebecca Silbermann, MD, MMS, outlines key trial design considerations in multiple myeloma, including supportive care measures and end point selection.]]>